A recent Delhi Government report has revealed that Indraprastha Apollo Hospital, one of the capital’s largest private healthcare institutions, attended to only 9–10% of patients from the Economically Weaker Sections (EWS) in its Outpatient Department (OPD) over the past five years — far below the
Apollo Hospitals begins offering the Antibody Cocktail (Casirivimab and Imdevimab) to patients with mild and moderate COVID and at high risk of developing severe COVID Indraprastha Apollo Hospitals, Delhi today announced that Roche India’s Antibody Cocktail (Casirivimab and Imdevimab) distributed by Cipla Ltd. is available for
Study shows that 97.38% of those vaccinated were protected from an infection and hospitalization rate was only 0.06% with mainly minor infections that do not lead to severe disease or hospitalization Hospital urges citizens to resist vaccine hesitancy to tide over the pandemic Indraprastha
